Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WNT3A | P56704 | 20/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17101041 | 0.90 | WNT3A (0.74) | WNT3A | |
| SCHEMBL16098950 | 0.88 | WNT3A (0.77) | WNT3A | |
| SCHEMBL17107956 | 0.88 | WNT3A (0.71) | WNT3A | |
| SCHEMBL17101096 | 0.87 | WNT3A (0.70) | WNT3A | |
| SCHEMBL17101546 | 0.87 | WNT3A (0.78) | WNT3A | |
| SCHEMBL17101076 | 0.87 | WNT3A (0.82) | WNT3A | |
| SCHEMBL17101034 | 0.87 | WNT3A (0.72) | WNT3A | |
| SCHEMBL17101072 | 0.86 | WNT3A (0.71) | WNT3A | |
| SCHEMBL17101049 | 0.86 | WNT3A (0.80) | WNT3A | |
| SCHEMBL17108179 | 0.86 | WNT3A (0.71) | WNT3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170114070-A1 | INHIBITORS OF THE WNT SIGNALLING PATHWAYS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-04-27 | — | — | US | disclosed |
| EP-3119787-A1 | INHIBITORS OF THE WNT SIGNALLING PATHWAYS | Bayer Pharma Aktiengesellschaft (DE) | 2017-01-25 | — | — | EP | disclosed |
| WO-2015140196-A1 | INHIBITORS OF THE WNT SIGNALLING PATHWAYS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2015-09-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170114070-A1 | INHIBITORS OF THE WNT SIGNALLING PATHWAYS | WNT1, WNT3A, CTNNB1 | WNT3A 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.